Both high insulin and glucose levels are postulated to drive PCa carcinogenesis in patients with T2D [10], however the exact underlying molecular mechanisms for the accelerated PCa progression in case of coexistent T2D is not determined yet. This evidence concerns the gene INS and type 2 diabetes mellitus.